Tower Research Capital LLC (Trc) Incyte Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Incyte Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,795 shares of INCY stock, worth $186,949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,795
Previous 3,554
49.49%
Holding current value
$186,949
Previous $242,000
37.19%
% of portfolio
0.0%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding INCY
# of Institutions
814Shares Held
205MCall Options Held
638KPut Options Held
635K-
Baker Bros. Advisors LP New York, NY30.7MShares$3.2 Billion21.24% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$2.22 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$2.08 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$1.45 Billion0.68% of portfolio
-
State Street Corp Boston, MA9.68MShares$1.01 Billion0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $23.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...